Physician profile
Chandler Mohan
NPI 1629239561
$957.51
in general payments reported to CMS, 2019-2025
22 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $88.95 · 2021: $180 · 2022: $52.35 · 2023: $146 · 2024: $103 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $226.86 | 2020-2025 | Slynd |
| Sumitomo Pharma America, INC. | $96.49 | 2024-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $85.88 | 2019-2023 | |
| Avion Pharmaceuticals | $61.89 | 2019-2020 | |
| Pfizer INC. | $57.38 | 2023-2024 | |
| Agile Therapeutics, INC. | $57.06 | 2021-2024 | Twirla |
| Hologic Sales and Service, LLC | $54.87 | 2019-2023 | Aptima |
| Vertex Pharmaceuticals Incorporated | $39.22 | 2025 | |
| Millicent US INC | $35.24 | 2025 | Femlyv |
| Mayne Pharma Commercial LLC | $33.55 | 2025 | |
| Lupin INC. | $24.63 | 2019 | |
| Abbvie INC. | $22.04 | 2019 | |
| Therapeuticsmd, INC. | $21.23 | 2021 | |
| Eisai INC. | $21.13 | 2019 | |
| Merck Sharp & Dohme LLC | $20.31 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $20.21 | 2021 | |
| Exact Sciences Corporation | $14.81 | 2023 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $13.79 | 2019 | |
| Myovant Sciences INC. | $13.76 | 2021 | |
| Organon LLC | $13.08 | 2021 | |
| Mission Pharmacal Company | $12.97 | 2019 | |
| Covidien LP | $11.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandler Mohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.